Journal article
The effect of physical activity on asthma incidence over 10 years: Population-based study
MA Russell, S Dharmage, E Fuertes, A Marcon, AE Carsin, SP Erquicia, J Heinrich, A Johannessen, MJ Abramson, AFS Amaral, I Cerveri, P Demoly, V Garcia-Larsen, D Jarvis, J Martinez-Moratalla, D Nowak, L Palacios-Gomez, G Squillacioti, W Raza, M Emtner Show all
Erj Open Research | Published : 2021
Open access
Abstract
Although there are many health benefits from being active, there was no benefit observed in this study from vigorous physical activity in reducing the risk of asthma onset in middle-aged adults https://bit.ly/3bEtHDn.
Grants
Awarded by Fondazione Cassa di Risparmio di Vercelli
Funding Acknowledgements
This study was supported by Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona; Comissio Interdepartamental de Recerca i Innovacio Tecnologica grant 1997 SGR 00079; Deutsche Forschungsgemeinschaft grants HE 3294/10-1, MA 711/6-1 and NO 262/7-1; National Health and Medical Research Council grant 92091; the Belgian Federal Science Policy Office; Estonian Science Foundation grant 1088; the Asthma Foundation of Victoria; Bundesministerium fur Forschung und Technologie; The Swiss The Federal Office of Public Health; Allen and Hanbury's; Wellcome Trust grant 084703MA; Helse Vest grant 911631; Ministre delegue de la sante; CNMATS; CNMRT grants 90MR/10 and 91AF/6; Haskoli Islands; the canton Lung Leagues of Basel Stadt/Basel, Landschaft, Geneva, Ticino, Valais and Zurich; INSERM Universite Bordeaux segalen grant U897; Comite Scientifique AGIRadom 2011; Ministere de la Sante Programme Hospitalier de Recherche Clinique (PHRC) national 2010; RNSP, France; Agence Nationale de la Sante, Region Ile de France, domaine d'interet majeur (DIM); the Bergen Medical Research Foundation; Medical Research Council grant 92091; a Vasterbotten County Council ALF grant; Direccion Regional de Salud Publica (Consejeria de Sanidad del Principado de Asturias); Lungenliga Schweiz; Contrat de Plan Etat-Region Languedoc-Rousillon; Insitut Pneumologique d'Aquitaine; the Swiss Federal Institute for Forest, Snow and Landscape Research; the canton governments of Aargan, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais and Zurich; Glaxo France; The Swiss Federal Office of Roads and Transport; Ministere de la Sante; Astma-och Allergiforbundet; the British Lung Foundation; the UK National Asthma Campaign; Hjart-Lungfonden; the UK Department of Health; The Landspitali University Hospital Research Fund; Hospital General Juan Ramon Jimenez; Medicinska Forskningsradet; Fondo de Investigacion Sanitaria grants 09/01511, 91/0016-060-05/E, 92/0319, 93/0393, PS09/00716, PS09/02185 and PS09/02457; Hospital General de Albacete; Italian Ministry of Health, Chiesi Farmaceutici SpA; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung grants 3100-059302, 3200-042532, 3200-052720, 3247-065896, 3247BO-104283, 3247BO-104284, 3247BO-104288, 33CSCO-108796, 33CSCO-134276/1, 4026-028099 and 4026-28099; Forskningsradet om Halsa, Arbetsliv och Valfard; Servicio Andaluz de Salud; Vegageroin (The Icelandic Road Administration (ICERA)); Orkuveita Reykjavikur (Geothermal plant); Fonds Wetenschappelijk Onderzoek grant G.0.410.08.N.10; Regione del Veneto grant 381/05.93; ResMed Foundation; Sociedad Espanola de Neumologia y Cirugia Toracica grant SEPAR 1001/2010; Forskningsradet for Arbetsliv och Socialvetenskap; and Norges Forskningsrad grant 101422/310. Funding information for this article has been deposited with the Crossref Funder Registry.